We trump tariffs on pharmaceuticals flagged - I think OPT will need to outsource their production for US market to a pharma manufacturer within the states. I don’t think this will be a big issue.
Opthea (OPT) - The BREAKTRHOUGH in Vision Treatment IMMINENT, page-17
Add to My Watchlist
What is My Watchlist?